4//SEC Filing
Palmer Ashleigh 4
Accession 0001493152-23-001782
CIK 0001695357other
Filed
Jan 17, 7:00 PM ET
Accepted
Jan 18, 4:01 PM ET
Size
5.7 KB
Accession
0001493152-23-001782
Insider Transaction Report
Form 4
Palmer Ashleigh
DirectorPresident and CEO10% Owner
Transactions
- Award
Stock Option (right to buy)
2023-01-17+700,000→ 700,000 totalExercise: $10.46Exp: 2033-01-17→ Common Stock, par value $0.0001 (700,000 underlying)
Footnotes (2)
- [F1]The options will vest and become exercisable as to 25% on the one-year anniversary of the grant date (January 17, 2024) and the remaining 75% will vest and become exercisable monthly over 36 months such that the options are fully vested and exercisable on the four-year anniversary of the grant date (January 17, 2027).
- [F2]The securities were granted pursuant to the Issuer's Amended and Restated 2017 Equity Incentive Plan.
Documents
Issuer
Provention Bio, Inc.
CIK 0001695357
Entity typeother
Related Parties
1- filerCIK 0001493714
Filing Metadata
- Form type
- 4
- Filed
- Jan 17, 7:00 PM ET
- Accepted
- Jan 18, 4:01 PM ET
- Size
- 5.7 KB